Medscape CME Internet-Based Activity

Brain Glucose Hypometabolism, Ketosis, and Alzheimer Disease:

From Controversy to Consensus CME

Target Audience:

This activity is intended for neurologists, primary care physicians, and other healthcare practitioners involved in the diagnosis and treatment of Alzheimer disease.

Learning Objectives:

1. Identify and evaluate the results of clinical research on brain glucose hypometabolism as a pathologic characteristic of Alzheimer disease
    
2. Describe the rationale for treatment to address brain glucose hypometabolism
    
3. Compare and contrast strategies to induce ketosis to address brain glucose hypometabolism